TY - JOUR
T1 - Complete spontaneous regression of multiple basal cell carcinomas in the basal cell nevus syndrome
T2 - The possible role of transepithelial elimination
AU - Kelley, R. S.
AU - Wagner, R. F.
AU - Sanchez, R. L.
AU - Duff, R. R.
PY - 1990
Y1 - 1990
N2 - A 36-year-old Latin American man with the basal cell nevus syndrome had multiple, soft, hairless, depressed scars of the face, scalp, neck, and back, ranging in size from 0.3 x 0.5 cm to 3.5 x 3.9 cm. These areas has never been treated and previously were sites of basal cell carcinomas that underwent complete spontaneous regression 4-5 years from the date of onset. Pathology of these spontaneously regressed sites was consistent with the criteria established by Curson and Weedon (1979). Type III transepithelial elimination was demonstrated for a basal cell carcinoma. Type III transepithelial elimination may play a role in the spontaneous regression of basal cell carcinomas.
AB - A 36-year-old Latin American man with the basal cell nevus syndrome had multiple, soft, hairless, depressed scars of the face, scalp, neck, and back, ranging in size from 0.3 x 0.5 cm to 3.5 x 3.9 cm. These areas has never been treated and previously were sites of basal cell carcinomas that underwent complete spontaneous regression 4-5 years from the date of onset. Pathology of these spontaneously regressed sites was consistent with the criteria established by Curson and Weedon (1979). Type III transepithelial elimination was demonstrated for a basal cell carcinoma. Type III transepithelial elimination may play a role in the spontaneous regression of basal cell carcinomas.
UR - http://www.scopus.com/inward/record.url?scp=0025602866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025602866&partnerID=8YFLogxK
U2 - 10.1111/j.1524-4725.1990.tb00328.x
DO - 10.1111/j.1524-4725.1990.tb00328.x
M3 - Article
C2 - 2246409
AN - SCOPUS:0025602866
SN - 0148-0812
VL - 16
SP - 1039
EP - 1042
JO - Journal of Dermatologic Surgery and Oncology
JF - Journal of Dermatologic Surgery and Oncology
IS - 11
ER -